· Weekly signal · REGN
Regeneron Pharmaceuticals Inc (REGN) reclaims momentum with 16.3% weekly advance
The four-week return has nearly matched the latest weekly jump, but inactive trend status and negative Market Dynamics keep confirmation mixed.
Regeneron Pharmaceuticals Inc (REGN) closed the latest week at 762.63 USD after a 16.3% advance on the weekly price path over 52 weeks. The gain pushed the biotechnology stock’s four-week return to 16.6%, extending a recent recovery within Healthcare.
Confirmation is not one-way. Weekly volume reached 5.19 million shares, above the 13-week average of 4.81 million, and Relative Strength stood at 1.7, but the trend signal is inactive and Market Dynamics at -0.23 still shows weakness.